The 20 Best Obesity in Children Doctors Near Me in Ann Arbor, MI

Megan Pesch is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Pesch is rated as a Distinguished provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Obesity in Children, Cytomegalovirus Antenatal Infection, Autism Spectrum Disorder, and Delayed Growth. Dr. Pesch is board certified in Developmental/Behavioral Pediatrics.

Dr. Kraftson specializes in treating patients with excess weight/obesity in addition to seeing patients with general endocrinologic conditions. He was inducted into the Clinical Excellence Society in 2021. He is the Director of the Weight Navigation Program & the Director of the Post Bariatric Endocrinology Clinic. Dr. Kraftson's research, focuses on gaining a better understanding of delivering effective care for individuals with obesity. In addition to these interests, Dr. Kraftson is actively involved in medical education and is the Associate Program Director for the M.E.N.D. Endocrinology Fellowship. Dr. Kraftson is rated as an Advanced provider by MediFind in the treatment of Obesity in Children. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Obesity, Malnutrition, Type 2 Diabetes (T2D), Gastric Bypass, and Sleeve Gastrectomy. Dr. Kraftson is board certified in Endocrinology, Diabetes & Metabolism.

Amy E. Rothberg, MD, DABOM is Clinical Professor of Internal Medicine in the Division of Metabolism, Endocrinology and Diabetes (MEND) and Director of the MEND Weight Management Clinic, Research Professor of Nutritional Sciences and Director of Rewind, a virtual weight management and diabetes treatment program. She is an adjunct Professor in the School of Public Health at the University of Michigan.Dr. Rothberg served both her internship and residency in the Department of Internal Medicine at the University of Michigan Medical Center in Ann Arbor. She then completed the fellowship program in the Metabolism, Endocrinology & Diabetes at the University of Michigan Health System in Ann Arbor and then joined the faculty.Dr. Rothberg holds, or is a Co-Investigator, on research grants from the Michigan Nutrition Obesity Research Center, the Michigan Diabetes Research Center, and the National Institutes of Health. Dr. Rothberg is rated as an Advanced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Obesity, Type 2 Diabetes (T2D), Obesity in Children, Familial Partial Lipodystrophy, and Gastric Bypass. Dr. Rothberg is board certified in Endocrinology, Diabetes & Metabolism.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Advanced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as an Advanced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is rated as an Advanced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy. Dr. Oral is board certified in Endocrinology, Diabetes & Metabolism.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Advanced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule. Dr. Sandouk is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Chun is a physician-scientist, who practices general endocrinology, including diabetes, thyroid diseases, and metabolic syndrome. His research is focused on the cellular and molecular mechanism of obesity, diabetes, and inflammatory and fibrotic tissue damages in endocrine disorders, such as Graves’ eye disease. Dr. Chun is rated as an Advanced provider by MediFind in the treatment of Obesity in Children. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, and Familial Isolated Hyperparathyroidism. Dr. Chun is board certified in Endocrinology, Diabetes & Metabolism and Internal Medicine.

Preethi Gogineni is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Gogineni is rated as an Advanced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Hyperparathyroidism, Type 1 Diabetes (T1D), Gestational Diabetes, and Osteoporosis.

Ram Menon is a Pediatric Endocrinologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Menon is rated as an Experienced provider by MediFind in the treatment of Obesity in Children. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Congenital Hypothyroidism, Short Stature (Growth Disorders), Pediatric Growth Hormone Deficiency, and Thyroidectomy. Dr. Menon is board certified in Pediatric Endocrinology.

David Olson earned his M.D. and Ph.D. at the University of Michigan (the latter in Cellular and Molecular Biology). He served his internship and residency at Children’s Hospital Boston, followed by a fellowship in pediatric endocrinology and metabolism at Children’s Hospital Boston/Joslin Diabetes Center. Prior to returning to the University of Michigan, Dr. Olson was on staff at Children's Hospital Boston and affiliated with the Department of Newborn Medicine at Brigham and Women’s Hospital. His postdoctoral research was performed at Beth Israel Deaconess Medical Center, Division of Endocrinology. Using novel mouse models, Dr. Olson is exploring gene expression changes in specific neuronal populations in the brain that are known to be important in regulating energy balance; these studies are directed at examining the link between gene expression in specific areas of the brain and altered metabolism. Additional studies using neuron-specific genetic changes are underway to clarify the molecular basis of daily biologic rhythms and explore how disruption of these rhythms predisposes organisms (rodents and humans) to pathologic changes in metabolism. Dr. Olson is rated as an Experienced provider by MediFind in the treatment of Obesity in Children. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Short Stature (Growth Disorders), Idiopathic Short Stature (ISS), and Familial Short Stature (FSS). Dr. Olson is board certified in Pediatric Endocrinology.

Brigid Gregg is a Pediatric Endocrinologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Gregg is rated as an Experienced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Obesity, Diabetes Insipidus (DI), and Neurohypophyseal Diabetes Insipidus.

Julie Lumeng is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Lumeng is rated as a Distinguished provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Obesity in Children, Postpartum Depression, and Premature Infant.

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as an Experienced provider by MediFind in the treatment of Obesity in Children. He is also highly rated in 105 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Gary D. Hammer, M.D., Ph.D. is Professor in Departments of InternalMedicine (MEND), Cell & Developmental Biology, and Molecular &Integrative Physiology. He currently serves as Director of EndocrineOncology Program in Rogel Cancer Center where he holds the MillieSchembechler Professorship in Adrenal Cancer. He is past Director ofCenter for Organogenesis: Stem Cells & Regenerative Medicine. He hasbrokered the recent renaissance of the current Michigan team of adrenalscientists that includes a who’s who in the study of adrenal disease.He received the UofM Jerome Conn Award for Outstanding Research inInternal Medicine, the Endocrine Society Edwin B. Astwood Award forOutstanding Research and is a member of ASCI and AAP. He has served innumerous leadership roles at UofM and in the public and private sectorsincluding recent tenure on Board of Scientific Advisors for NCI. He isthe editor of four textbooks including Pathophysiology of Disease: AnIntroduction to Clinical Medicine (McGraw Hilll), and the upcomingAdrenal Section Editor for Degroot’s Endocrinology (Elsevier). He hasserved in numerous capacities for the world’s largest endocrineorganization, the Endocrine Society including his most recent role asPresident of the Society (2020-2021). An Advisor to the CongressionalH.E.L.P. committee - he co-authored the 21st Century Cancer ALERT(Access to Life-Saving Early detection, Research and Treatment) Act’’ lintroduced in Congress in 2009. He has been catalyst for the formationof two international cooperative groups, most recently the A5 (AmericanAustralian Asian Adrenal Alliance) that leverages collaboration tosecure projects from Pharma and funding agencies across the spectrum ofadrenal diseases. He is a cofounder of two companies - MILLENDO andSLING THERAPEUTICS that focus on rare endocrine diseases. Dr. Hammer is rated as an Experienced provider by MediFind in the treatment of Obesity in Children. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Neuroblastoma, and Hereditary Neuroblastoma. Dr. Hammer is board certified in Endocrinology, Diabetes & Metabolism.

Nevin Ajluni, M.D., joined the team at the Division of Metabolism, Endocrinology & Diabetes (MEND) after serving a two-year endocrinology fellowship in the Division. She is a part of the care team in the MEND Weight Management Program, where she works with obese individuals by applying cutting-edge research findings and novel clinical strategies. She is an honors graduate of the Wayne State University School of Medicine and completed her internship and residency in internal medicine at the McGaw Medical Center of Northwestern University before coming to the University of Michigan. Dr. Ajluni is rated as an Experienced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), and Congenital Generalized Lipodystrophy. Dr. Ajluni is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Merve Kutahyalioglu M.D., is a Clinical Assistant Professor in the Division of Metabolism, Endocrinology, and Diabetes. She completed her internal medicine internship and residency at the University of Texas Health Science Center, and endocrinology fellowship training at the Baylor College of Medicine. She is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. Dr. Kutahyalioglu joined the faculty at the University of Michigan in 2021. She has an interest in general endocrinology. She is a part of the care team in the MEND Weight Management and MEND Post-Bariatric Surgery Care Program. Dr. Kutahyalioglu is rated as an Experienced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Malnutrition, Type 1 Diabetes (T1D), Obesity in Children, and Hyperparathyroidism. Dr. Kutahyalioglu is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Nieves is rated as an Experienced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar. Dr. Nieves is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Jennifer Franzese is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Franzese is rated as an Experienced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroid Nodule.

Maria Papaleontiou, MD, is an Associate Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes, and a Research Associate Professor at the Institute of Gerontology, at the University of Michigan. Prior to starting her internal medicine residency at Saint Peter's University Hospital in New Jersey, she spent several years conducting clinical research on aging at Weill Cornell Medical College in New York City. She completed her endocrinology fellowship at the University of Michigan, where she subsequently joined the faculty in 2013. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. Her clinical practice focuses on thyroid diseases and thyroid cancer, as well as geriatric endocrinology.Dr. Papaleontiou is also a health services researcher in the field of thyroidology and aging. Her research focuses on evaluating the risks of thyroid hormone overtreatment and misuse in older adults, understanding the role of providers and patients in thyroid hormone use and misuse and how it relates to patient outcomes in the aging population, as well as the role of age and comorbidity in thyroid cancer decision-making. Her ultimate goal is to develop tools to tailor thyroid disease treatment to older adults by translating research findings into effective strategies and interventions to improve the care of older adults and reduce patient harm. She has received funding from the National Institute on Aging, the Claude D. Pepper Older American Independence Centers, the University of Michigan Biology of Cardiovascular Aging Core and the Elizabeth Caroline Crosby Research Award. She serves on multiple national committees including at the American Thyroid Association (ATA), the Endocrine Society, the American Association of Clinical Endocrinology and the North American Society for Interventional Thyroidology. She has served as Co-Chair for the ATA’s Annual Program Committee (2021-2022), Chair of the ATA’s Women in Thyroidology (2022-2023) and Vice-Chair for AACE's Thyroid Disease State Network (2022-2023). She is an Associate Editor for Endocrine Practice, and serves on the Editorial Boards for Thyroid and BMC Endocrine Disorders. Dr. Papaleontiou is rated as an Experienced provider by MediFind in the treatment of Obesity in Children. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Hypothyroidism, Thyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Papaleontiou is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.